Is there a standard regimen for first-line treatment of advanced/metastatic Non-Small-Cell Lung Cancer? What has meta-analyses contributed to today's standard of care-Reference-Cited by-同舟云学术

Is there a standard regimen for first-line treatment of advanced/metastatic Non-Small-Cell Lung Cancer? What has meta-analyses contributed to today's standard of care

Published:2012-03 Issue:3 Volume:75 Page:269-274
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Pallis Athanasios G.,Georgoulias Vassilis

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference49 articles.

1. Cancer statistics;Jemal;CA Cancer J Clin,2009

2. Estimates of the cancer incidence and mortality in Europe in 2006;Ferlay;Ann Oncol,2007

3. Clinical features of 5,628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003;Yang;Chest,2005

4. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database;Govindan;J Clin Oncol,2006

5. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003;Pfister;J Clin Oncol,2004

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of endostatin combined with PT-DC versus bevacizumab combined with PT-DC in the first-line treatment of advanced lung adenocarcinoma: a retrospective propensity score- matched cohort study;Annals of Palliative Medicine;2021-07

2. Minimally invasive lobectomy with neoadjuvant targeted therapy: the Zhejiang Cancer Hospital experience;Journal of Thoracic Disease;2019-01

3. Patterns of care of nonsmall cell lung cancer patients in China and implications for survival;Journal of Cancer Research and Therapeutics;2018

4. Mitochondria-Targeted Hydroxyapatite Nanoparticles for Selective Growth Inhibition of Lung Cancer in Vitro and in Vivo;ACS Applied Materials & Interfaces;2016-09-21

5. Oral vinorelbine plus cisplatin followed by maintenance oral vinorelbine as first-line treatment for advanced non-small cell lung cancer;Cancer Chemotherapy and Pharmacology;2015-05-30